Anthony P. Zook insider trades
Open-market stock purchases and sales by Anthony P. Zook, Chief Executive Officer at Neogenomics Inc, from SEC Form 4 filings since Jul 25, 2013.
Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +154%.